Entry |
|
Name |
Oxazepam (JAN/USP/INN); Serax (TN) |
Product |
|
Generic |
|
Formula |
C15H11ClN2O2
|
Exact mass |
286.0509
|
Mol weight |
286.713
|
Structure |
|
Simcomp |
|
Class |
Neuropsychiatric agent
DG01914 Anxiolytics, benzodiazepine derivatives
|
Remark |
|
Efficacy |
Minor tranquilizer |
Comment |
Benzodiazepine derivative
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Structure map |
map07230 | GABA-A receptor agonists/antagonists |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05B ANXIOLYTICS
N05BA Benzodiazepine derivatives
N05BA04 Oxazepam
D00464 Oxazepam (JAN/USP/INN) <US>
USP drug classification [BR:br08302]
Anxiolytics
Benzodiazepines
Oxazepam
D00464 Oxazepam (JAN/USP/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01914 Anxiolytics, benzodiazepine derivatives
D00464 Oxazepam
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D00464 Oxazepam (JAN/USP/INN) <US>
Narcotics and psychotropics in Japan [br08308.html]
Psychotropics by Cabinet order Article 3 (78 substances)
D00464
|
Other DBs |
|
KCF data |
ATOM 20
1 C2y C 19.1034 -15.6194
2 C8y C 18.2613 -14.5098
3 C8y C 18.5965 -13.1530
4 N1x N 19.8575 -12.5749
5 N2x N 20.5092 -15.6446
6 C5x C 21.1111 -13.1972
7 C1y C 21.3976 -14.5659
8 C8x C 17.5894 -12.1846
9 C8x C 16.2474 -12.5727
10 C8y C 15.9122 -13.9295
11 C8x C 16.9193 -14.8976
12 O1a O 22.7288 -15.0030
13 O5x O 22.1552 -12.2628
14 X Cl 14.5474 -14.3239
15 C8y C 18.4689 -16.8691
16 C8x C 17.0673 -16.8691
17 C8x C 16.3673 -18.0816
18 C8x C 17.0673 -19.2940
19 C8x C 18.4689 -19.2940
20 C8x C 19.1689 -18.0816
BOND 22
1 3 4 1
2 1 5 2
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 1
8 3 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 2 11 2
13 7 12 1
14 6 13 2
15 10 14 1
16 1 15 1
17 15 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 19 20 1
22 15 20 2
|